Cargando…
CRISPR-Cas9-mediated reactivation of the uricase pseudogene in human cells prevents acute hyperuricemia
The utility of CRISPR-Cas9 to repair or reverse diseased states that arise from recent genetic mutations in the human genome is now widely appreciated. The use of CRISPR to “design” the outcomes of biology is challenged by both specialized ethicists and the general public. Less of a focus, however,...
Autores principales: | de Lima Balico, Lais, Gaucher, Eric A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8463316/ https://www.ncbi.nlm.nih.gov/pubmed/34589279 http://dx.doi.org/10.1016/j.omtn.2021.08.002 |
Ejemplares similares
-
Uricase-deficient rat is generated with CRISPR/Cas9 technique
por: Yu, Yun, et al.
Publicado: (2020) -
Oral Delivery
of Nanoparticles Carrying Ancestral
Uricase Enzyme Protects against Hyperuricemia in Knockout Mice
por: Tran, Lily, et al.
Publicado: (2023) -
Quality Control Strategy for CRISPR-Cas9-Based Gene Editing Complicated by a Pseudogene
por: Hanss, Zoé, et al.
Publicado: (2020) -
Phylogenetic Articulation of Uric Acid Evolution in Mammals and How It Informs a Therapeutic Uricase
por: Li, Ze, et al.
Publicado: (2021) -
Uricase alkaline enzymosomes with enhanced stabilities and anti-hyperuricemia effects induced by favorable microenvironmental changes
por: Zhou, Yunli, et al.
Publicado: (2016)